| Literature DB >> 17823757 |
Lianet Monzote1, Ana Margarita Montalvo, Ramón Scull, Migdalia Miranda, Juan Abreu.
Abstract
To date, there are no vaccines against Leishmania, and chemotherapy remains the mainstay for the control of leishmaniasis. The drugs of choice used for leishmaniasis therapy are significantly toxic, expensive and with a growing frequency of refractory infections. Because of these limitations, a combination therapy is the better hope. This work demonstrates that the essential oil from Chenopodium ambrosioides shows a synergic activity after incubation in conjunction with pentamidine against promastigotes of Leishmania amazonensis. However, an indifferent effect has been found for combinations of meglumine antimoniate or amphotericin B and the essential oil.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17823757 DOI: 10.1590/s0036-46652007000400012
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846